Skip to Main Content

1,104

Views

0

CrossRef citations to date

0

Altmetric

Original Research

Exposure–efficacy relationship of vedolizumab subcutaneous and intravenous formulations in Crohn’s disease and ulcerative colitis

Geert D’Haensa Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, NetherlandsCorrespondence[email protected]
View further author information

,

Maria Rosariob Takeda Development Center Americas Inc, Cambridge, MA, USAView further author information

,

Daniel Polhamusc Metrum Research Group, Tariffville, CT, USAView further author information

,

Nathanael L. Dirksc Metrum Research Group, Tariffville, CT, USAView further author information

,

Chunlin Chenb Takeda Development Center Americas Inc, Cambridge, MA, USAView further author information

,

Krisztina Kisfalvib Takeda Development Center Americas Inc, Cambridge, MA, USAView further author information

,

Christian Agbotonb Takeda Development Center Americas Inc, Cambridge, MA, USAView further author information

,

Séverine Vermeired Translational Research in GastroIntestinal Disorders, University Hospitals Leuven, Leuven, BelgiumView further author information

,

Brian G. Feagane Robarts Clinical Trials, Western University, London, Ontario, CanadaView further author information

&

William J. Sandbornf Division of Gastroenterology, University of California San Diego, La Jolla, CA, USAView further author information